President Donald Trump on Tuesday signed a memorandum that aims to crack down on direct-to-consumer prescription drug ads, in a move that stops short of an outright ban. The pharmaceutical industry’s ability to advertise drugs directly to consumers has long been a target of Health and Human Services Secretary Robert F. Kennedy Jr., who floated a ban on those ads in November and has argued that they lead Americans to use more prescription medications. But senior administration officials on

See Full Page